These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12523450)

  • 21. Executive function in abstinent MDMA ('ecstasy') users.
    Zakzanis KK; Young DA
    Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Carlson RG; Falck RS; McCaughan JA; Siegal HA
    J Psychoactive Drugs; 2004 Jun; 36(2):181-9. PubMed ID: 15369199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of learning, memory, and executive function in new MDMA users.
    Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Durdle H; Lundahl LH; Johanson CE; Tancer M
    Depress Anxiety; 2008; 25(3):241-7. PubMed ID: 17345601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Emotion regulation among psychostimulants drug users at techno parties].
    Lillaz C; Varescon I
    Encephale; 2012 Oct; 38(5):390-6. PubMed ID: 23062452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
    Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
    Murphy PN; Wareing M; Fisk J
    J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative experiences on Ecstasy: the role of drug, set and setting.
    McElrath K; McEvoy K
    J Psychoactive Drugs; 2002; 34(2):199-208. PubMed ID: 12691210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users.
    Zakzanis KK; Young DA; Radkhoshnoud NF
    Appl Neuropsychol; 2002; 9(2):84-91. PubMed ID: 12214826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes.
    Marsden J; Stillwell G; Barlow H; Boys A; Taylor C; Hunt N; Farrell M
    Addiction; 2006 Jul; 101(7):1014-26. PubMed ID: 16771893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
    Falck RS; Wang J; Carlson RG
    J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE; Montgomery C; Murphy P; Wareing M
    Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New age seekers: MDMA use as an adjunct to spiritual pursuit.
    Watson L; Beck J
    J Psychoactive Drugs; 1991; 23(3):261-70. PubMed ID: 1685513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
    Golding JF; Groome DH; Rycroft N; Denton Z
    Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Falck RS; Carlson RG; Wang J; Siegal HA
    Drug Alcohol Depend; 2004 Apr; 74(1):45-54. PubMed ID: 15072806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
    Matthews A; Bruno R; Johnston J; Black E; Degenhardt L; Dunn M
    Drug Alcohol Depend; 2009 Feb; 100(1-2):24-31. PubMed ID: 19013726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.